GlassScriptPhysician profile
Saira Dar
NPI 1366412165
$3,276.55
in general payments reported to CMS, 2019-2025
18 companies · $24.64 in 2025
The $24.64 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.96 · 2020: $40.51 · 2021: $3,014 · 2022: $102 · 2023: $32.85 · 2025: $24.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $2,400.00 | 2021 | |
| Abbvie INC. | $373.11 | 2021-2023 | Vraylar |
| Supernus Pharmaceuticals, INC. | $72.66 | 2021 | |
| Sunovion Pharmaceuticals INC. | $56.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $54.05 | 2021 | |
| Janssen Pharmaceuticals, INC | $53.41 | 2019-2021 | |
| Ge Healthcare | $36.44 | 2019 | |
| Jazz Pharmaceuticals INC. | $31.25 | 2021 | |
| Vanda Pharmaceuticals INC. | $29.90 | 2022 | |
| Allergan, INC. | $26.12 | 2020 | |
| Glaxosmithkline, LLC. | $24.64 | 2025 | Arexvy, Shingrix, Bexsero |
| Alkermes, INC. | $20.26 | 2021 | |
| Abbott Laboratories | $19.21 | 2022 | |
| Tris Pharma INC | $18.99 | 2021 | |
| Ironshore Pharmaceuticals INC. | $18.17 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.65 | 2021 | |
| Organon LLC | $14.07 | 2023 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saira Dar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.